Adherex Technologies Aktie
WKN DE: A12A5F / ISIN: CA31447P1009
|
14.08.2025 12:14:37
|
Fennec Pharmaceuticals Inc Q2 Loss Decreases, But Misses Estimates
(RTTNews) - Fennec Pharmaceuticals Inc (FENC) announced Loss for second quarter that decreased from last year but missed the Street estimates.
The company's earnings totaled -$3.15 million, or -$0.11 per share. This compares with -$5.55 million, or -$0.20 per share, last year.
Analysts on average had expected the company to earn -$0.03 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 32.9% to $9.65 million from $7.26 million last year.
Fennec Pharmaceuticals Inc earnings at a glance (GAAP) :
-Earnings: -$3.15 Mln. vs. -$5.55 Mln. last year. -EPS: -$0.11 vs. -$0.20 last year. -Revenue: $9.65 Mln vs. $7.26 Mln last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Adherex Technologies Incmehr Nachrichten
|
13.08.25 |
Ausblick: Adherex Technologies stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net) | |
|
13.05.25 |
Ausblick: Adherex Technologies vermeldet Zahlen zum jüngsten Quartal (finanzen.net) |
Analysen zu Adherex Technologies Incmehr Analysen
Aktien in diesem Artikel
| Adherex Technologies Inc | 7,40 | 7,25% |
|